Page last updated: 2024-08-07 23:04:28
Protein O-GlcNAcase
A protein O-GlcNAcase that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60502]
Synonyms
OGA;
EC 3.2.1.169;
Beta-N-acetylglucosaminidase;
Beta-N-acetylhexosaminidase;
Beta-hexosaminidase;
Meningioma-expressed antigen 5;
N-acetyl-beta-D-glucosaminidase;
N-acetyl-beta-glucosaminidase;
Nuclear cytoplasmic O-GlcNA
Research
Bioassay Publications (12)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 8 (66.67) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Compounds (4)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
thiamet g | Homo sapiens (human) | EC50 | 0.0210 | 1 | 1 |
Modification of the Thioglycosyl-Naphthalimides as Potent and Selective Human O-GlcNAcase Inhibitors.ACS medicinal chemistry letters, , Dec-13, Volume: 9, Issue:12, 2018
OGA inhibition by GlcNAc-selenazoline.Bioorganic & medicinal chemistry, , Oct-01, Volume: 18, Issue:19, 2010
N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines.Bioorganic & medicinal chemistry letters, , May-01, Volume: 18, Issue:9, 2008
Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease.European journal of medicinal chemistry, , Aug-05, Volume: 238, 2022
AcBioorganic & medicinal chemistry letters, , 03-15, Volume: 29, Issue:6, 2019
Sugar Kick Prevents Memory Impairment.Journal of medicinal chemistry, , 11-27, Volume: 62, Issue:22, 2019
Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies.Journal of medicinal chemistry, , 11-27, Volume: 62, Issue:22, 2019
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.Journal of medicinal chemistry, , 04-26, Volume: 61, Issue:8, 2018
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.European journal of medicinal chemistry, , Oct-20, Volume: 139, 2017
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.Nature chemical biology, , Volume: 4, Issue:8, 2008
Enables
This protein enables 4 target(s):
Target | Category | Definition |
hyalurononglucosaminidase activity | molecular function | Catalysis of the random hydrolysis of (1->4) linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. [EC:3.2.1.35] |
identical protein binding | molecular function | Binding to an identical protein or proteins. [GOC:jl] |
[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity | molecular function | Catalysis of the reaction: 3-O-(N-acetyl-beta-D-glucosaminyl)-L-seryl/L-threonyl-[protein] + H2O = L-seryl//L-threonyl-[protein] + N-acetyl-D-glucosamine. [EC:3.2.1.169] |
beta-N-acetylglucosaminidase activity | molecular function | Catalysis of the hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues in N-acetyl-beta-D-glucosaminides. [EC:3.2.1.52, MetaCyc:3.2.1.52-RXN] |
Located In
This protein is located in 3 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
membrane | cellular component | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. [GOC:dos, GOC:mah, ISBN:0815316194] |
Involved In
This protein is involved in 5 target(s):
Target | Category | Definition |
N-acetylglucosamine metabolic process | biological process | The chemical reactions and pathways involving N-acetylglucosamine. The D isomer is a common structural unit of glycoproteins in plants, bacteria and animals; it is often the terminal sugar of an oligosaccharide group of a glycoprotein. [ISBN:0198506732] |
protein O-linked glycosylation | biological process | A protein glycosylation process in which a carbohydrate or carbohydrate derivative unit is added to a protein via the hydroxyl group of peptidyl-serine, peptidyl-threonine, peptidyl-hydroxylysine, or peptidyl-hydroxyproline, or via the phenol group of peptidyl-tyrosine, forming an O-glycan. [GOC:pr, ISBN:0879695595, RESID:AA0153, RESID:AA0154, RESID:AA0155, RESID:AA0157, RESID:AA0212] |
glycoprotein catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of a glycoprotein, a protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide. [GOC:go_curators, ISBN:0198506732] |
protein deglycosylation | biological process | The removal of sugar residues from a glycosylated protein. [GOC:mah] |
glycoprotein metabolic process | biological process | The chemical reactions and pathways involving glycoproteins, a protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide. [GOC:go_curators, ISBN:0198506732] |